Literature DB >> 4148430

The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations.

M G Collis, B J Alps.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4148430     DOI: 10.1111/j.2042-7158.1973.tb10648.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  8 in total

1.  α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man.

Authors:  C De B White; A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

Review 2.  A basis for migraine therapy- the autonomic theory reappraised.

Authors:  E S Johnson
Journal:  Postgrad Med J       Date:  1978-04       Impact factor: 2.401

3.  The evaluation of the novel pressor activity of gamma-piperidinobutyramide (WY 20051, DF480).

Authors:  B J Alps; P W Devoy; J F Waterfall
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

4.  Double-blind trial of indoramin in digital artery disease.

Authors:  P Robson; V Pearce; A C Antcliff; M Hamilton
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

5.  Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.

Authors:  C de White; R B Royds; P Turner
Journal:  Postgrad Med J       Date:  1974-12       Impact factor: 2.401

Review 6.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

7.  The action of indoramin and other compounds on the uptake of neurotransmitters into rat cortical slices.

Authors:  R F Sugden
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

8.  Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.

Authors:  A J Marshall; M A Kettle; D W Barritt
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.